“Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s120. https://doi.org/10.25251/skin.4.supp.120.